Title : ARK5 promotes doxorubicin resistance in hepatocellular carcinoma via epithelial-mesenchymal transition.

Pub. Date : 2016 Jul 28

PMID : 27126361






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 ARK5 promotes doxorubicin resistance in hepatocellular carcinoma via epithelial-mesenchymal transition. Doxorubicin NUAK family kinase 1 Homo sapiens
2 In this study, we found that SNU387 and SNU449 HCC cell lines overexpressing ARK5 displayed low doxorubicin sensitivity compared to Huh7 and Hep3B HCC cell lines with ARK5 low-expression. Doxorubicin NUAK family kinase 1 Homo sapiens
3 And knockdown of ARK5 increased the doxorubicin sensitivity in all HCC cell lines in the manner of inhibiting cell proliferation. Doxorubicin NUAK family kinase 1 Homo sapiens
4 Moreover, suppressing ARK5 by siRNA restored E-cadherin and vimentin expression induced by doxorubicin treatment or hypoxia culture. Doxorubicin NUAK family kinase 1 Homo sapiens
5 Our results indicated ARK5 confers doxorubicin resistance in HCC via inducing EMT. Doxorubicin NUAK family kinase 1 Homo sapiens